All Stories

  1. Emerging drugs for progressive supranuclear palsy

    Article • Expert Opinion on Emerging Drugs, April 2019, Taylor & Francis

    Dr Maria Stamelou

  2. Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease

    Article • Movement Disorders, October 2018, Wiley

    Dr Maria Stamelou

  3. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease

    Article • Movement Disorders, October 2018, Wiley

    Dr Maria Stamelou

  4. Tremor in motor neuron disease may be central rather than peripheral in origin

    Article • European Journal of Neurology, August 2018, Wiley

    Dr Maria Stamelou

  5. Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society

    Article • Movement Disorders, November 2017, Wiley

    Dr Maria Stamelou

  6. Treatable inherited rare movement disorders

    Article • Movement Disorders, September 2017, Wiley

    Dr Maria Stamelou, Dr Mayela Rodríguez-Violante

  7. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    Article • Movement Disorders, September 2017, Wiley

    Dr Maria Stamelou, Dr Andres Lozano, Hagai Bergman, A Jon Stoessl, Dr Mayela Rodríguez-Violante

  8. TMEM230 : How does it fit in the etiology and pathogenesis of Parkinson's disease?

    Article • Movement Disorders, June 2017, Wiley

    Dr Maria Stamelou

  9. Which ante mortem clinical features predict progressive supranuclear palsy pathology?

    Article • Movement Disorders, May 2017, Wiley

    Dr Maria Stamelou, Professor Irene Litvan

  10. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

    Article • Movement Disorders, May 2017, Wiley

    Dr Maria Stamelou, Professor Irene Litvan

  11. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    Article • Movement Disorders, May 2017, Wiley

    Dr Maria Stamelou

  12. Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials

    Article • Movement Disorders, April 2017, Wiley

    Dr Maria Stamelou

  13. Manual MRI morphometry in Parkinsonian syndromes

    Article • Movement Disorders, February 2017, Wiley

    Dr Maria Stamelou

  14. Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

    Article • Movement Disorders, March 2016, Wiley

    Dr Maria Stamelou, Professor Irene Litvan

  15. Late-onset cerebellar ataxia: Do not forget Friedreich's

    Article • Movement Disorders, January 2016, Wiley

    Dr Maria Stamelou

  16. The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

    Article • Movement Disorders, November 2014, Wiley

    Dr Leslie Ferguson, Dr Maria Stamelou

  17. Commentary

    Article • Movement Disorders, March 2014, Wiley

    Dr Maria Stamelou